Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kelman

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Circulation|November 1, 2014
Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillationDavid J Graham, Marsha E Reichman, Michael Wernecke, et al.
The American Journal of Psychiatry|June 15, 2022
Mortality Among Parkinson's Disease Patients Treated With Pimavanserin or Atypical Antipsychotics: An Observational Study in Medicare BeneficiariesAndrew D Mosholder, Yong Ma, Sandia Akhtar, et al.
The American Journal of Medicine|January 15, 2019
Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial FibrillationDavid J Graham, Elande Baro, Rongmei Zhang, et al.
JAMA Internal Medicine|October 4, 2016
Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial FibrillationDavid J Graham, Marsha E Reichman, Michael Wernecke, et al.
JAMA Internal Medicine|November 1, 2021
Risk of Guillain-Barré Syndrome Following Recombinant Zoster Vaccine in Medicare BeneficiariesRavi Goud, Bradley Lufkin, Jonathan Duffy, et al.
Journal of General Internal Medicine|November 25, 2024
Antipsychotics and Risk of Acute Respiratory Failure in U.S. Medicare Beneficiaries with Chronic Obstructive Pulmonary DiseaseSilvia Perez-Vilar, Andrew D Mosholder, Elizabeth R Smith, et al.
Pharmacotherapy|October 19, 2024
Use of proton pump inhibitors and risk of severe COVID-19: A case-control study in United States Medicare beneficiariesAndrew D Mosholder, Hector S Izurieta, Rongmei Zhang, et al.
Vaccine|December 10, 2022
Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and olderHui-Lee Wong, Ellen Tworkoski, Cindy Ke Zhou, et al.
Vaccine|May 4, 2024
Assessment of potential adverse events following the 2022-2023 seasonal influenza vaccines among U.S. adults aged 65 years and olderXiangyu Chianti Shi, Joann F Gruber, Michelle Ondari, et al.
JAMA|November 18, 2015
Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron ProductsCunlin Wang, David J Graham, Robert C Kane, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Circulation|November 1, 2014
Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillationDavid J Graham, Marsha E Reichman, Michael Wernecke, et al.
The American Journal of Psychiatry|June 15, 2022
Mortality Among Parkinson's Disease Patients Treated With Pimavanserin or Atypical Antipsychotics: An Observational Study in Medicare BeneficiariesAndrew D Mosholder, Yong Ma, Sandia Akhtar, et al.
The American Journal of Medicine|January 15, 2019
Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial FibrillationDavid J Graham, Elande Baro, Rongmei Zhang, et al.
JAMA Internal Medicine|October 4, 2016
Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial FibrillationDavid J Graham, Marsha E Reichman, Michael Wernecke, et al.
JAMA Internal Medicine|November 1, 2021
Risk of Guillain-Barré Syndrome Following Recombinant Zoster Vaccine in Medicare BeneficiariesRavi Goud, Bradley Lufkin, Jonathan Duffy, et al.
Journal of General Internal Medicine|November 25, 2024
Antipsychotics and Risk of Acute Respiratory Failure in U.S. Medicare Beneficiaries with Chronic Obstructive Pulmonary DiseaseSilvia Perez-Vilar, Andrew D Mosholder, Elizabeth R Smith, et al.
Pharmacotherapy|October 19, 2024
Use of proton pump inhibitors and risk of severe COVID-19: A case-control study in United States Medicare beneficiariesAndrew D Mosholder, Hector S Izurieta, Rongmei Zhang, et al.
Vaccine|December 10, 2022
Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and olderHui-Lee Wong, Ellen Tworkoski, Cindy Ke Zhou, et al.
Vaccine|May 4, 2024
Assessment of potential adverse events following the 2022-2023 seasonal influenza vaccines among U.S. adults aged 65 years and olderXiangyu Chianti Shi, Joann F Gruber, Michelle Ondari, et al.
JAMA|November 18, 2015
Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron ProductsCunlin Wang, David J Graham, Robert C Kane, et al.
Pageof 11